Related Experiment Video
Updated: Jul 9, 2025

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
MICROS: Asthma Control App for School Adolescents in a Low Resource Setting - A Cluster Randomized Controlled Trial
James Davis Katumba1, Bruce Kirenga2, Anthony Muwagga Mugagga3
1Clinical Epidemiology Unit, College of Health Sciences, Makerere University, Kampala, Uganda.
The KmAsthma app improved asthma control in Ugandan adolescents. This mobile health intervention offers a low-resource solution for better asthma self-management and education.
Area of Science:
- Adolescent Health
- Digital Health Interventions
- Respiratory Medicine
Background:
- Adolescent asthma control is often poor due to insufficient self-management education.
- Low-resource settings present unique challenges for asthma care and education.
Purpose of the Study:
- To determine the effectiveness of the "KmAsthma" mobile health (mHealth) self-management app.
- To improve asthma control among adolescents in a low-resource setting (Kampala, Uganda).
Main Methods:
- A 6-month cluster randomized controlled trial involving 120 adolescents (12-19 years) with uncontrolled asthma.
- The intervention group used the "KmAsthma" app for education and self-management, covering goals, symptoms, medication reminders, and emergency support.
- Primary outcome: change in mean Asthma Control Test (ACT) scores. Secondary outcomes: quality of life, medication adherence, and self-efficacy.
Main Results:
- The study is designed to measure improvements in asthma control, quality of life, adherence, and self-efficacy.
- Expected to demonstrate the feasibility and impact of mHealth in improving adolescent asthma management.
Conclusions:
- The MICROS study will offer insights into the efficacy of mHealth for adolescent asthma self-management in low-resource environments.
- Findings aim to address the gap in satisfactory asthma control among adolescents, informing future interventions.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
04:24A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...